News

Zacks Investment Research on MSN21h
ABBV or BMY: Which Biopharma Giant Has Better Prospects for Now?
AbbVie, Inc. ABBV and Bristol Myers Squibb BMY are leading drugmakers with broad and diverse portfolios and a global footprint. AbbVie is a global, diversified biopharmaceutical company with a ...
Medscape21h
Digital Tech for Schizophrenia on the Brink of a Breakthrough?
Digital technology may be on the verge of ‘breaking out’ for schizophrenia treatment, but numerous questions will need to be ...
CBS News3d
FDA declares end to Wegovy and Ozempic shortage - CBS News
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
'Dimmer switch' drug candidates offer hope for safer nerve pain and ischemic disease treatments
Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions ...
PureTech Announces Board Change
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today ...
PureTech Health plc: PureTech Announces Board Change
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today annou ...